Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BI 11054 Safety and PK in Healthy Males
NCT02273401Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 2008
- Primary completion
- Aug 2008
01
Overview
Phase 1, randomised, double-blind trial of BI 11054 CL in asthma and chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Jan 2008; status: completed.
02
Drugs
BI 11054 CL
03
Conditions
asthmachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02273401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02273401.